MAGISNAT LAUNCH – June, 23rd 2022
On June 23rd 2022, a virtual event that will be hosted in the Press Room of the Italian Chamber of Deputies in Rome for the presentation of the new spin-off MagisNat (www.magisnat.com), to promote research on the Mediterranean diet and the food supplements from natural molecules. The event will be attended by numerous researches and professors, some of which will be present telematically, both from Italy and the United States of America, who will try to raise awareness in society on very delicate issues such as eating disorders—in particular its two extremes, obesity and anorexia—and the study of natural molecules.
MAGISNAT's Spin-Off Presentation at Georgia State Capitol, Atlanta - 13th December, 2023
On December 13th, MAGISNAT presented, during a press conference hosted inside the Georgia State Capitol, six patents focused on the use of omics approaches to study major human metabolic pathways. MAGISNAT presented its “OMICS Machine” using omics testing for personalized dietary supplementation, already available in the market. Major current research focus on the oral inflammation, on investigating genes associated with lipedema, and on critical aspects like the regulation of appetite.
“I strongly believe in the potential of the US market. We found an incredible pro-business environment in the State of Georgia, and I want to thank all the people and entities which are helping us in our establishment here” said Matteo Bertelli, MAGISNAT President and CEO. “We founded MAGISNAT in order to increase our collaboration with U.S. researchers with whom we have been collaborating and publishing scientific papers for a long time”.
“Gwinnett County hosts more than 600 international and foreign companies, we want them to growth here.” said Nick Masino, Charmain of the Gwinnett Chamber of Commerce, while Deven Cason, Vice President Economic Development Partnership Gwinnett remarked “We are here to give tools and information to the companies who believe in the potential of our County.”
Andrew Hickey from Partnership Gwinnett, Robin Bienfait and Nashlee Young from Atlanta Tech Park, EJane Caraway from the Georgia State Business Development Department also attended the press conference.
Dr. Kevin Donato, who has been appointed as MAGISNAT Deputy CEO during the last Board of Directors, explained MAGISNAT strategies for the United States.
In conclusion, MAGISNAT’s strategic settlement in the Atlanta Tech Park marks a significant milestone in the pursuit of its innovative vision rooted in omics science. The company, under the leadership of Dr. Matteo Bertelli, is poised to contribute groundbreaking advancements to the study of physiological regulatory processes, with a focus on enhancing human well-being. With its pioneering “OMICS Machine” and a portfolio of six patents, MAGISNAT demonstrates its commitment to leveraging omics methodologies for personalized dietary supplementation and addressing critical health concerns.
MAGISNAT's Scientific Meeting at Atlanta Tech Park, Peachtree Corners - 14th December, 2023
On December 14th, MAGISNAT, held a Scientific Meeting at Atlanta Tech Park in Peachtree Corners, GA. The event aimed to share MAGISNAT’s mission, philosophy, latest research, and innovative patents. MAGISNAT scientists presented, emphasizing the company’s dedication to using advanced approaches to understand the body’s natural healing mechanisms and enhance overall well-being.
The speakers were: Nashlee Young and Robert Bienfait from Atlanta Tech Park; Bertrand Lapoire from the City of Peachtree Corners; Andrew Hickey from the Partnership Gwinnett; Matteo Bertelli, MAGISNAT – MAGISNAT Spin-Off Presentation; Kevin Donato, MAGISNAT – “MAGISNAT Personalized Approach”; Gabriele Bonetti, MAGISNAT – “Innovative Approaches: Treating Lipedema” and “Targeting Oral Mucositis: A Comprehensive Approach”; Maria Chiara Medori, MAGISNAT – “Branched-Chain Amino Acids for Anorexia and Cachexia”; Pietro Chiurazzi, MAGISNAT – “Exploring the Future: Patents and Spin-Offs in Well-being”
Personalized Approach to Wellness
MAGISNAT’s unique approach to wellness is centered on tailoring dietary supplementation and lifestyle interventions based on individual biological characteristics with omics tests, such as genomics, metabolomics and proteomics, the company’s OMICS Machine model provides personalized recommendations for optimizing nutrition, physical activity, and dietary supplements.*
Emerging Innovations
During the Scientific Meeting, MAGISNAT unveiled five innovative patents that address key health challenges:
- OMICS Machine: A model that integrates multi-omics data to build a map describing the major molecular pathways in the human body. The model can optimize and personalize lifestyle, dietary supplementation, and physical activity.
- Genetic Mechanism for Lipedema Prevention: AKR1C1, a steroid metabolizing enzyme, has been identified as a key factor in lipedema susceptibility. Using bioinformatics, MAGISNAT has developed small molecules to compete with hormones introduced in the diet, preventing lipedema onset.
- Modulation of Adipose Tissue Growth and Inflammation: In vitro and metabolomics studies have identified sodium cromoglycate, a molecule capable of modulating mast cell activity, as a potential treatment for lipedema.
- Amino Acid Ratios for Appetite Regulation: Specific amino acid ratios have been shown to play a crucial role in appetite regulation. MAGISNAT’s patented approach utilizes these amino acids to modulate appetite.
- Natural Approach to Oral Mucositis Prevention and Treatment: A patented gel composition, which includes Lactobacillus reuteri, a beneficial bacterium naturally found in the oral cavity during early life but present in only 1 percent of adults, serves as a natural approach for preventing and treating oral mucositis.
Advancing Wellness Through Science
MAGISNAT employs omics techniques to examine the body’s natural processes that sustain its balanced health, embodying a futuristic perspective on well-being. The focus is on comprehending the complex molecular pathways in the human body and investigating natural, alternative ways to restore balance. The Scientific Meeting underscores MAGISNAT’s commitment to scientific innovation, emphasizing dedication to improving individual well-being with personalized solutions. MAGISNAT’s groundbreaking patents represent significant progress in understanding the human body and developing tailored interventions that support overall health without relying on traditional methods.
MAGISNAT was founded to enhance collaboration with U.S. researchers, with whom MAGISNAT researchers have initiated a long-standing collaboration and extensive research that has led to the publication of scientific articles. Our commitment aligns with the philosophy articulated by Thomas Edison: ‘The doctor of the future will give no medication but will interest his patients in the care of the human frame, diet, and in the cause and prevention of disease.’ Edison’s foresight echoes MAGISNAT’s founding principles, emphasizing alternative and natural approaches to well-being.
